MedPath

CLOFARABINE

These highlights do not include all the information needed to use CLOFARABINE INJECTION safely and effectively. See full prescribing information for CLOFARABINE INJECTION. CLOFARABINE injection, for intravenous use Initial U.S. Approval: 2004

Approved
Approval ID

18adf4af-63ed-41e6-ab59-87085ce3e5fb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 10, 2022

Manufacturers
FDA

Eugia US LLC

DUNS: 968961354

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CLOFARABINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-326
Application NumberANDA212457
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOFARABINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 21, 2020
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CLOFARABINEActive
Quantity: 1 mg in 1 mL
Code: 762RDY0Y2H
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOFARABINE - FDA Drug Approval Details